Tamar Feuerstein

Schneider Children's Medical Center — Israel

Medicine · Health Sciences

6h-index269citations17works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(10), Acute Myeloid Leukemia Research(6), Lymphoma Diagnosis and Treatment(4), CAR-T cell therapy research(4), Childhood Cancer Survivors' Quality of Life(3)

Publications17 total

A Nationwide Analysis of the Phenotype/Genotype Landscape of Hemophagocytic Lymphohistiocytosis: UNC13D Associates with Poor Prognosis
Genes·2025Open Access
CAR T-cells dysfunction in the central nervous system is mediated by BBB-induced activation-induced cell death
2025Open Access
Flow-cytometric MRD detection in pediatric T-ALL: a multicenter AIEOP-BFM consensus-based guided standardized approach
Clinical Chemistry and Laboratory Medicine (CCLM)·2025· 1 citedOpen Access
CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment
Blood·2024· 11 cited
<scp>FCM</scp> marker importance for <scp>MRD</scp> assessment in <scp>T‐cell</scp> acute lymphoblastic leukemia: An <scp>AIEOP‐BFM‐ALL‐FLOW</scp> study group report
Cytometry Part A·2023· 10 citedOpen Access
Author response for "&lt;scp&gt;FCM&lt;/scp&gt; marker importance for &lt;scp&gt;MRD&lt;/scp&gt; assessment in &lt;scp&gt;T‐Cell&lt;/scp&gt; Acute Lymphoblastic Leukemia: An &lt;scp&gt;AIEOP‐BFM‐ALL‐FLOW&lt;/scp&gt; Study Group Report"
2023
Author response for "&lt;scp&gt;FCM&lt;/scp&gt; marker importance for &lt;scp&gt;MRD&lt;/scp&gt; assessment in &lt;scp&gt;T‐Cell&lt;/scp&gt; Acute Lymphoblastic Leukemia: An &lt;scp&gt;AIEOP‐BFM‐ALL‐FLOW&lt;/scp&gt; Study Group Report"
2023
Early‐life liver cirrhosis and variable clinical presentation in telomere disease
Acta Paediatrica·2022· 2 cited
Independence and Entrepreneurship Among Arab Muslim Rural and Bedouin Women in Israel
2022· 4 cited
An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report
Cancers·2021· 32 citedOpen Access
Pediatric myelodysplastic syndrome with inflammatory manifestations: Diagnosis, genetics, treatment, and outcome
Pediatric Blood & Cancer·2021· 6 cited
Blinatumomab as a bridge to further therapy in cases of overwhelming toxicity in pediatric B‐cell precursor acute lymphoblastic leukemia: Report from the Israeli Study Group of Childhood Leukemia
Pediatric Blood & Cancer·2019· 31 cited
CD371 cell surface expression: a unique feature of <i>DUX4</i>-rearranged acute lymphoblastic leukemia
Haematologica·2019· 61 citedOpen Access
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia
Blood·2018· 107 citedOpen Access
Acute Leukemia of Ambiguous Lineage: A Comprehensive Survival Analysis Enables Designing New Treatment Strategies
Blood·2016· 2 cited
The Junior Files: File 1, English for Today and Tomorrow
TESOL Quarterly·1993· 1 cited
Teaching Reading Skills and Strategies.
English Teachers' Journal·1992· 1 cited

Frequent Co-authors

Ondřej Hrušák(9), Michael Dworzak(9), Barbara Buldini(9), Angela Schumich(7), Giuseppe Gaipa(7), Margarita Maurer‐Granofszky(7), Ester Mejstříková(5), Giuseppe Basso(5), Shai Izraeli(5), Simona Sala(5), Peter Švec(4), Martin Schrappe(4), Monika Brüggemann(4), Michaela Nováková(4), Giovanni Faggin(4), Markéta Žaliová(3), Anja Möricke(3), Jorge G. Rossi(3), Marı́a Sara Felice(3), Myriam Campbell(3)